Hedge Funds Are Crazy About Synta Pharmaceuticals Corp. (SNTA)

Page 2 of 2

With the results demonstrated by our studies, retail investors should always pay attention to hedge fund and insider trading sentiment, and Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is no exception.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Trinity Biotech plc (ADR) (NASDAQ:TRIB) 10 0 0
Meridian Bioscience, Inc. (NASDAQ:VIVO) 9 2 5
SurModics, Inc. (NASDAQ:SRDX) 8 0 2
Quidel Corporation (NASDAQ:QDEL) 5 0 3
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) 10 0 2
Page 2 of 2